A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

A new clinical trial shows the immunotherapy drug dostarlimab may eliminate the need for surgery and chemotherapy in certain ...

Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of ...

In a groundbreaking cancer study, researchers found that immunotherapy drugs alone can treat gastrointestinal tumours.For as ...

An analysis of emergency visits related to the active ingredient in drugs like Ozempic and Wegovy has exposed a surprising ...

Approximately two-thirds of patients responded to teduglutide, which is sold under the brand name Gattex as a treatment for ...

Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...

“The future of gastrointestinal drug delivery maybe driven by rapid advancements in patient-centered design and technologies that enhance drug delivery specificity, precise targeting and cost ...

The Indian Council of Medical Research (ICMR) has recommended a ban on Nimesulide for individuals under 18 and over 60 due to ...